Probability of default median for public healthcare companies by industry US 2020-2021

In 2020, public pharmaceutical companies in the United States had a 7.7 percent probability of default at its peak. However, the probability decreased to 1.6 percent as of March 2021. This statistic illustrates the 1-year probability of default median for public U.S. healthcare companies comparing the 2020-high to March 2021, by primary industry.

One-year probability of default median for public U.S. healthcare companies 2020-high vs. March 2021, by industry

Characteristic	2020 high*	March 8, 2021
Pharmaceuticals	7.7%	1.6%
Healthcare distributors	4.2%	1.5%
Biotechnology	4.1%	1.1%
Healthcare facilities	8.1%	0.9%
Healthcare supplies	3.4%	0.8%
Healthcare technology	3.2%	0.8%
Healthcare services	4.3%	0.7%
Health equipment	3.4%	0.6%
Life sciences and services	2.4%	0.6%
Managed healthcare	3.6%	0.6%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

May 2021

More information

Region

United States

Survey time period

as of March 9, 2021

Supplementary notes

Data consists of one-year market signal scores as of March 8, 2021. Probability of defaul scores calculated using S&P GlobalMarket Intelligence's Market SIgnal probability of default model, which is based primarily on volatility of share prices, taking into account country and industry-related risks.
* Represents the highest daily 1-year probability of default median for each sector in 2020.

Citation formats